Search Results for

S2104

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Continue Reading »

---

EA2192

A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial

Continue Reading »

---

S2001

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

Continue Reading »

---

A021806

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Continue Reading »

---

EA2186

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (8)    Metastatic  (3)    Neoadjuvant  (4) Brain  (7)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (15)    1st Line Metastatic Breast, Metastasis at Presentation or Progression of earlier Disease  (3)    Breast Cancer Adjuvant  (3)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (22) Carcinoid Tumors  (1) Colorectal Cancer  (8)    Metastatic  (3)    Rectal Neoadjuvant  (1) Esophageal Cancer  (2) Gall Bladder/ Biliary Tract Cancer  (2) Gastric Cancer  (1)    Metastaic Gastric Cancer  (1) Head/Neck Cancer  (5)    Resectable Oral Cavity Cancer  (1)       Primary Chemoradiation Regimens  (1) Leukemia  (6)    Acute Myeloid Leukemia (AML)  (1)    B-Cell Chromic Lymphocytic Leukemia (CLL) / Small Ly  (3) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (28)    Non-Small Cell Lung Cancer  (19)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (5)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (3)       Adjuvant Treatment for Resected NSCLC  (4)    Small Cell Lung Cancer  (9)       Extensive Stage SCLC  (6) Lymphoma  (5)    Non-Hodgkin’s Lymphoma  (2)       Follicular Lymphoma  (1)          Relapsed/Refractory  (1) MATCH Trial  (1) MDS  (3) Melanoma  (5)    Metastatic  (2) Merkel Cell Carcinoma  (1) Multiple Myeloma  (2) Pancreatic  (5)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (4)    Locally Advanced/Metastatic  (4) Sarcoma  (2) Small Bowel  (1)